Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on ...

Apertura Gene Therapy and the TSC Alliance Announce Collaboration to Advance Gene Therapy Programs Designed to Treat Tuberous Sclerosis Complex (TSC)

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...
WBAL-TV

World-renowned Maryland neurologist to run marathon in honor of TSC patients

MINDY: DR. PETER CRINO IS TRAINING FOR THE NEW YORK CITY MARATHON. IT’S MORE THAN JUST A RACE FOR HIM, IT’S AN OPPORTUNITY TO RAISE AWARENESS AND FUNDING FOR A RARE GENETIC DISEASE THAT HE TREATS, ...

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsyAUSTIN, Texas, May 05, ...
Medscape

Adjunctive Cannabidiol Improves Neuropsychiatric Symptoms in TSC

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.
The Newtown Bee

Step Forward For A Cure: Living With Tuberous Sclerosis Complex

: This article has been updated. Upon first glance, Georgie Merusi looks like any other 4-year-old. He enjoys things that ...
News Medical

Study could help understand how Tuberous Sclerosis Complex arises

Tuberous Sclerosis Complex (TSC) affects between one and two of every 10,000 new-born babies. This genetic disease leads to the formation of benign tumors which can massively impair the proper ...